Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Phosphonatoformate
Drug ID BADD_D01767
Description An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpes viruses and HIV.
Indications and Usage For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.
Marketing Status Prescription; Discontinued
ATC Code J05AD01
DrugBank ID DB00529
KEGG ID D00579
MeSH ID D017245
PubChem ID 3414
TTD Drug ID D0OT0O
NDC Product Code Not Available
Synonyms Foscarnet | Phosphonoformic Acid | Foscarnet Trisodium Salt | Foscarnet Calcium (2:3) Salt | Foscarnet Disodium Salt | Foscarnet Magnesium (2:3) Salt | Trisodium Phosphonoformate | Phosphonoformate | Foscarnet Sodium | Foscarnet Trilithium Salt | Foscarnet Tripotassium Salt | Foscarnet Sodium Hexahydrate | Foscavir | Foscarnet Barium (2:3) Salt | Foscarnet Manganese (2+) (2:3) Salt
Chemical Information
Molecular Formula CO5P-3
CAS Registry Number 4428-95-9
SMILES C(=O)([O-])P(=O)([O-])[O-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mouth ulceration07.05.06.004--Not Available
Muscle contractions involuntary15.05.03.008; 17.05.03.001--Not Available
Muscle spasms15.05.03.004--
Muscular weakness17.05.03.005; 15.05.06.001--
Myalgia15.05.02.001--
Myopathy15.05.05.001--Not Available
Myositis15.05.01.001--
Nausea07.01.07.001--
Neoplasm16.16.02.001--Not Available
Nephrolithiasis20.04.01.002--
Nephropathy toxic20.05.03.002; 12.03.01.010--Not Available
Nervousness19.06.02.003--Not Available
Neuropathy peripheral17.09.03.003--Not Available
Neutropenia01.02.03.004--Not Available
Nocturia20.02.03.001--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Pain08.01.08.004--
Palpitations02.01.02.003--
Pancreatitis07.18.01.001--
Pancytopenia01.03.03.003--Not Available
Paraesthesia17.02.06.005--
Pharyngitis22.07.03.004; 07.05.07.004; 11.01.13.003--
Platelet disorder01.08.03.001--Not Available
Pneumothorax22.05.02.003--
Polyuria20.02.03.002--Not Available
Pruritus23.03.12.001--
Pseudolymphoma01.09.01.016--Not Available
Rash23.03.13.001--Not Available
Rash erythematous23.03.06.003--Not Available
Rash maculo-papular23.03.13.004--
The 4th Page    First    Pre   4 5 6    Next   Last    Total 6 Pages